460 related articles for article (PubMed ID: 20001556)
1. Targeting the transforming growth factor-beta signaling pathway in human cancer.
Nagaraj NS; Datta PK
Expert Opin Investig Drugs; 2010 Jan; 19(1):77-91. PubMed ID: 20001556
[TBL] [Abstract][Full Text] [Related]
2. Overlapping activities of TGF-β and Hedgehog signaling in cancer: therapeutic targets for cancer treatment.
Perrot CY; Javelaud D; Mauviel A
Pharmacol Ther; 2013 Feb; 137(2):183-99. PubMed ID: 23063491
[TBL] [Abstract][Full Text] [Related]
3. TGF-β Signaling in Cancer.
Syed V
J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor β signaling pathway: A promising therapeutic target for cancer.
Chen Y; Di C; Zhang X; Wang J; Wang F; Yan JF; Xu C; Zhang J; Zhang Q; Li H; Yang H; Zhang H
J Cell Physiol; 2020 Mar; 235(3):1903-1914. PubMed ID: 31332789
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in TGF-β inhibitors for cancer therapy.
Huang CY; Chung CL; Hu TH; Chen JJ; Liu PF; Chen CL
Biomed Pharmacother; 2021 Feb; 134():111046. PubMed ID: 33341049
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta signaling in cancer treatment.
Fabregat I; Fernando J; Mainez J; Sancho P
Curr Pharm Des; 2014; 20(17):2934-47. PubMed ID: 23944366
[TBL] [Abstract][Full Text] [Related]
7. Large- and small-molecule inhibitors of transforming growth factor-beta signaling.
Akhurst RJ
Curr Opin Investig Drugs; 2006 Jun; 7(6):513-21. PubMed ID: 16784021
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β: A therapeutic target for cancer.
Haque S; Morris JC
Hum Vaccin Immunother; 2017 Aug; 13(8):1741-1750. PubMed ID: 28575585
[TBL] [Abstract][Full Text] [Related]
9. Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression.
Jones E; Pu H; Kyprianou N
Expert Opin Ther Targets; 2009 Feb; 13(2):227-34. PubMed ID: 19236240
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta in cancer and metastasis.
Jakowlew SB
Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
[TBL] [Abstract][Full Text] [Related]
11. TGF-β signaling in cancer.
Gu S; Feng XH
Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):941-949. PubMed ID: 30165534
[TBL] [Abstract][Full Text] [Related]
12. Exploring anti-TGF-β therapies in cancer and fibrosis.
Hawinkels LJ; Ten Dijke P
Growth Factors; 2011 Aug; 29(4):140-52. PubMed ID: 21718111
[TBL] [Abstract][Full Text] [Related]
13. SMAD-oncoprotein interplay: Potential determining factors in targeted therapies.
Li X; Feng XH
Biochem Pharmacol; 2020 Oct; 180():114155. PubMed ID: 32682760
[TBL] [Abstract][Full Text] [Related]
14. A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment.
Huynh LK; Hipolito CJ; Ten Dijke P
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31744193
[TBL] [Abstract][Full Text] [Related]
15. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.
Halder SK; Beauchamp RD; Datta PK
Neoplasia; 2005 May; 7(5):509-21. PubMed ID: 15967103
[TBL] [Abstract][Full Text] [Related]
16. Development of TGF-beta signalling inhibitors for cancer therapy.
Yingling JM; Blanchard KL; Sawyer JS
Nat Rev Drug Discov; 2004 Dec; 3(12):1011-22. PubMed ID: 15573100
[TBL] [Abstract][Full Text] [Related]
17. TGF-β signaling in cancer metastasis.
Xie F; Ling L; van Dam H; Zhou F; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):121-132. PubMed ID: 29190313
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta antiproliferative effects in tumor suppression.
Jahn SC; Law ME; Corsino PE; Law BK
Front Biosci (Schol Ed); 2012 Jan; 4(2):749-66. PubMed ID: 22202088
[TBL] [Abstract][Full Text] [Related]
19. The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy.
Grusch M; Petz M; Metzner T; Oztürk D; Schneller D; Mikulits W
Curr Cancer Drug Targets; 2010 Dec; 10(8):849-57. PubMed ID: 20718708
[TBL] [Abstract][Full Text] [Related]
20. Targeting TGF-β Signaling in Cancer.
Colak S; Ten Dijke P
Trends Cancer; 2017 Jan; 3(1):56-71. PubMed ID: 28718426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
